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Introduction
Cryptococcus neoformans is a fungal pathogen which causes
severe infections in immunocompromised individuals, for ex-
ample, AIDS patients and patients going through organ trans-
plantation.[1] C. neoformans is surrounded by capsular polysac-
charides (CPSs), primarily the glucurono-xylo-mannan (GXM)-
polysaccharide comprising 90–95% of the total capsule mass.
The structure of the GXM is believed to be built up of triads,
that is, substituted a-(1!3) linked trisaccharide mannans, as
depicted in Figure 1. b-glucuronic acid residues are linked to
position 2 of the mannose backbone, together with a heteroge-
neous pattern of 2- and/or 4-b-xylose substituents. The
amount of xylose substitution is the major determinant for the
serotyping, with serotype B and C being the more substituted.
GXM is also heterogeneously acetylated with the acetate posi-
tioned at the 6-OH of the mannose backbone but not present
in the residues carrying 4-O-xylose.[2] The acetylation is be-
lieved to be important for virulence for Serotypes A and D.[3]
Our main focus is on Serotypes A and D, which are the most
common ones in human infections, but we are also interested
in 4-O-xylosyl containing motifs usually attributed to Seroty-
pes B and C, since these structures, owing to the large hetero-
geneity of the CPS, are present in minor quantities also in CPSs
serotyped as A or D. Furthermore, Serotype C structures have
the lowest degree of acetylation, which should simplify struc-
ture–activity interpretation of immunological results. A build-
ing block synthetic strategy for Serotype A and D structures
using 2-O-substituted disaccharides (I–III, Figure 2)[4–9] has been
developed, but the use of 2,4-di-O-substituted trisaccharide
building blocks has not been investigated in detail. The syn-
theses of both the 2,4-di-O-Xyl (IV, Figure 2)[10] and the 2-O-
GlcA-[4-O-Xyl] (V, Figure 2)[6,11] substituted trisaccharide thiogly-
coside building blocks have been published, but only the
former has been used in glycosylations and then only as
As part of an ongoing project aimed at identifying protective
capsular polysaccharide epitopes for the development of vac-
cine candidates against the fungal pathogen Cryptococcus neo-
formans, the synthesis and glycosylation properties of a naph-
thalenylmethyl (NAP) orthogonally protected trisaccharide thio-
glycoside, a common building block for construction of sero-
type B and C capsular polysaccharide structures, were investi-
gated. Ethyl (benzyl 2,3,4-tri-O-benzyl-b-d-glucopyranosyl-
uronate)-(1!2)-[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!4)]-6-
O-benzyl-3-O-(2-naphthalenylmethyl)-1-thio-a-d-mannopyrano-
side was prepared and used both as a donor and an acceptor
in glycosylation reactions to obtain spacer equipped hexa- and
heptasaccharide structures suitable either for continued elon-
gation or for deprotection and printing onto a glycan array or
conjugation to a carrier protein. The glycosylation reactions
proceeded with high yields and a-selectivity, proving the via-
bility of the building block approach also for construction of 4-
O-xylosyl-containing C. neoformans CPS structures.
Figure 1. Suggested structures of C. neoformans GXM serotype triads.
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a donor. The potential use of block V as donor or as acceptor
to form heavily branched 2,3,4-tri-substituted mannose motifs
has not been explored.
A slightly different approach to the one we are pursuing has
been investigated by Zhao and Kong[12,13] on the syntheses of
non-acetylated methyl glycoside structures of Serotype B.
These capsular polysaccharide fragments were prepared fol-
lowing a mixed convergent-linear strategy. In particular, the
xylose-substituted trisaccharide mannan backbone was con-
structed before, and the glucuronic acid (GlcA) was introduced
in the final step.
When the mannose residue involved in the glycosylation
was at the nonreducing end in a hexasaccharide acceptor (Fig-
ure 3A), no reaction was observed with methyl 2,3,4-tri-O-
acetyl bromo- or trichloroacetimidate GlcA donors.[12]
However, when the mannose residue was at the reducing
end of the hexasaccharide acceptor (Figure 3B), the glycosyla-
tion proceeded smoothly (78% yield), affording the target
non-acetylated heptasaccharide structural motif.[13] Noteworthy,
this latter strategy failed when the same glycosylation was per-
formed on Serotype C heptasaccharide acceptor (Figure 3,
C).[14] The conflicting outcomes of GlcA glycosylation decrease
the attractiveness of this strategy in the preparation of larger
GXM fragments.
Herein, our recent efforts in the preparation of the orthogo-
nally protected building block type V are reported together
with its use in the construction of larger spacer-containing ace-
tylated part structures following a convergent approach.
Results and Discussion
In our previous synthesis,[6] building block V was prepared with
an allyl group as the temporary protecting group in position 3.
However, in light of results obtained in attempts to remove
the allyl group on disaccharide thioglycosides, showing its in-
compatibility with the thioethyl group,[9] the allyl group was
changed into a naphthalenylmethyl protecting group (NAP) in
the new synthesis (Scheme 1).
Starting from compound 1,[7] the benzylidene ring was
opened regioselectively with NaCNBH3/HCl
[15] obtaining com-
pound 4-OH acceptor 2 in 93% yield. The coupling of 2 and
3[16] was carried out using trimethylsilyl trifluoromethanesulfo-
nate (TMSOTf) in the presence of (commercial) acid-washed
molecular sieves to prevent orthoester formation and afford
compound 4 in 70% yield. At this stage, benzoyl groups,
which ensured the stereoselective course of the glycosylation,
were removed and the primary OH was selectively protected
by reaction with tert-butyldimethylsilyl chloride (TBDMSCl)
giving 6 in 61% yield over two steps. The remaining hydroxy
groups were per-benzylated (!7, 77%) before compound 8
was obtained in an almost quantitative yield (96%) by reaction
with tetra-n-butylammonium fluoride (TBAF).
NMR analysis of compound 8 at 25 8C in CDCl3 gave unex-
pected results, which included broad peaks in the 1H NMR
spectrum and even missing carbon peaks in the 13C NMR spec-
trum (Figure 4).
By carrying out the NMR experiments at 50 8C (Figure 4B),
sharper peaks (1H NMR) and expected peaks (13C NMR) were
observed. In particular, the cross peak for C¢1’’ as well as the
two anomeric carbons for C¢1’ and C¢1’’ were visible. Still, no
signal was observed for position 4 of the mannose residue.
Figure 2. Desired thioglycoside building blocks. R=persistent protecting
group, orthoghonal to the acetyl group; R2= temporary protecting group,
orthoghonal to R and acetyl groups.
Figure 3. Schematic representation of GlcA glycosylation of xylose-substitut-
ed trisaccharide mannan backbone, reported previously.[12–14]
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This behaviour is in agreement
with hindered rotation for com-
pound 8.[17] Interestingly, the
NMRs of the related com-
pounds 7 and 9 do not show
this behaviour.
Final oxidation with the
(2,2,6,6-tetramethylpiperidin-1-
yl)oxyl-[bis(acetoxy)iodo]ben-
zene (TEMPO-BAIB)[18] system
followed by benzylation of the
crude (Cs2CO3, BnBr) afforded
the desired building block 9 in
satisfactory 60% yield.
Scheme 1. Reagents and conditions : a) NaCNBH3, HCl (1m in Et2O), THF, pH 1–2, 20 8C, 30 min, 93%; b) TMSOTf, CH2Cl2, AW-300 MS, ¢78 8C!0 8C, o/n, 70%;
c) 1. NaOMe, MeOH, 20 8C, o/n; 2. Dowex H+ ion-exchange resin, 80%; d) TBDMSCl, pyridine, DMAP, 20 8C, 4 h, 76%; e) NaH, BnBr, DMF, 0 8C!20 8C, o/n, 77%;
f) TBAF trihydrate, THF, 20 8C, 2 h, 96%; g) 1) TEMPO, BAIB, CH2Cl2/H2O (2:1), 20 8C; 2) Cs2CO3, BnBr, DMF, 0 8C!20 8C, 2 h, 60%.
Figure 4. A) 1H¢13C HSQC spectrum of compound 8 at 25 8C; B) 1H¢13C HSQC spectrum of compound 8 at 50 8C;
the now visible anomeric cross peak is highlighted.
Scheme 2. Reagents and conditions : a) DMTST, Et2O, 0 8C!20 8C, 1.5 h, 95% for 11, 79% for 14 ; b) DDQ, CH2Cl2/H2O (10:1), 20 8C, 60 min, 74%; c) H2/Pd¢C
(30 bar), EtOAc, H2O, AcOH, 67%.
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Prepared trisaccharide 9 was tested in a dimethyl(methyl-
thio)sulfonium trifluoromethansulfonate (DMTST)-promoted
glycosylation with the spacer-containing derivative 10[10]
(Scheme 2) and afforded a-linked tetrasaccharide 11 as the
sole product in 95% yield, demonstrating excellent donor
properties of trisaccharide 9 to monosaccharide acceptors.
The removal of the naphthalenylmethyl protecting group by
reaction with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ)
in a mixture of dichloromethane/water proceeded in 74%
yield to obtain acceptor 12 ready for testing the possibility of
obtaining 2,3,4-tri-O-glycosylated structures. Thus, acceptor 12
was reacted with disaccharide thioglycoside 13[9] again using
DMTST as promoter. Satisfactorily, hexasaccharide 14 was ob-
tained with complete a-selectivity and in high yield (79%) and
was then completely deprotected by means of hydrogenolysis
to afford 15 in 67% yield. This rather unusual GXM structural
motif was reported recently by Nimrichter et al.[19] who charac-
terised a substituted triad from encapsulated cells that had
only been described in polysaccharide fractions from a hypo-
capsular mutant. NMR data for 15 are in good agreement with
the one reported for the polysaccharide: anomeric reported
values: 4.45 ppm (GlcA), 4.35 ppm (2-O-Xyl), 4.25 ppm (4-O-
Xyl) ; found for 15 4.47 ppm (GlcA), 4.40 ppm (2-O-Xyl),
4.31 ppm (4-O-Xyl).
A more complex acceptor than the monosaccharide 10 was
then prepared to further investigate the donor properties of
trisaccharide 9 (Scheme 3 and 4). Spacer-equipped acceptor
17, obtained from 16[10] in 88% yield, was coupled with tri-
chloroacetimidate donor 3[16] using tert-butyldimethylsilyl tri-
fluoromethanesulfonate (TBDMSOTf) in the presence of acid-
washed molecular sieves yielding disaccharide 18 in 86% yield.
Benzoyl groups, again utilised for their anchimeric assistance in
the glycosylation reaction, were exchanged for benzyl groups
affording 20 in 77% yield over two steps. The opening of the
benzylidene ring was this time performed using Bu2BOTf/
BH3
[20] to afford the opposite regioselectivity to compound 1,
giving the 6-OH compound 21 (76%), which was either acety-
lated (!22, 93%) or benzylated (!23, 95%). The 6-O-acetyl
disaccharide 22 was then chosen for the preparation of a tetra-
saccharide acceptor for the consecutive construction of the
spacer-containing C. neoformans Serotype B heptasaccharide
triad motif which followed our standard sequence of reactions:
NAP removal followed by DMTST-promoted glycosylation
(Scheme 4).
The first reaction gave disaccharide acceptor 24 in 73%
yield, while the glycosylation with 25[9] afforded tetrasacchar-
ide 26 in 85% yield, which was in turn converted into the new
acceptor 27 (80% yield). As mentioned in the introduction,
Scheme 3. Reagents and conditions : a) Bu2SnO, Bu4NBr, NapBr, toluene, reflux, 3 h, 88%; b) TBDMSOTf, CH2Cl2, AW-300 MS, ¢78 8C!20 8C, o/n, 86%;
c) 1. NaOMe, MeOH, 20 8C; 2. Dowex H+ ion-exchange resin, 86%; d) NaH, BnBr, DMF, 0 8C!20 8C, 3 h, 90%; e) Bu2BOTf, BH3 (1m in THF), CH2Cl2, 0 8C, 90 min,
76%; f)Ac2O, pyridine, 20 8C, 3 h, 93%; g) NaH, BnBr, DMF, 0 8C!20 8C, 2 h, 95%.
Scheme 4. Reagents and conditions : a) DDQ, CH2Cl2/H2O (10:1), 20 8C, 60 min, 73% for 24, 80% for 27; b) DMTST, Et2O, 0 8C!20 8C, 3.5 h, 85%.
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acetates are heterogenously present on the 6-OH of mannose
residues if no 4-O-xylose substituents are present. By choosing
the correct combination from the set of thioglycoside donors
(13 and 25) and spacer-containing acceptors (24 and the one
that can be prepared from 23 after NAP removal), and by fol-
lowing the same sequence of reactions reported in Scheme 4,
all possible acetylation patterns on the tetrasaccharide motif
can be obtained, permitting following investigation into the
effect of the acetylation pattern on the immune response.
Finally, building block 9 was used in the glycosylation reac-
tion with 27 to prepare the desired structural motif
(Scheme 5).
The reaction proceeded smoothly (83%) and permitted, for
the first time, the synthesis of monoacetyl heptasaccharide 28.
This result, together with the preparation of tetrasaccharide
11, confirmed the versatility of the proposed convergent strat-
egy which allows for installation of the GlcA containing trisac-
charide in every position of the mannan triad thus overcoming
the problems encountered previously with different strategies.
Derivative 28 could be completely deprotected by hydrogenol-
ysis, as shown for 14, and used to prepare a candidate vaccine
after conjugation with an immunogenic protein, or could be
employed as an acceptor after removal of the NAP group
(!29, 68%), to further elongate the GXM fragment.
Conclusions
In conclusion, an efficient synthesis of a GlcA-containing trisac-
charide thioglycoside building block corresponding to Crypto-
coccus neoformans Serotype B and C glucurono-xylo-mannan
(GXM) oligosaccharide structure has been developed. The
naphthalenylmethyl (NAP)-protected building block was
shown to be a most efficient glycosyl donor to both monosac-
charide and more complex acceptors in dimethyl(methylthio)-
sulfonium-trifluoromethansulfonate (DMSTS)-promoted glyco-
sylation reactions which proceeded with high yields and com-
plete a-selectivity. Subsequent removal of the 2-NAP tempora-
ry protecting group converted obtained saccharides into new
acceptors, which were shown to work well in following glyco-
sylation reactions allowing effective construction of heavily
branched 2,3,4-subtituted motifs. Thus, the presented strategy
permitted the preparation of both a hexasaccharide (14) and
a Serotype B heptasaccharide structural motif, and the results
demonstrate the possible synthesis of any C. neoformans GXM
structure from the various available mono-, di-, and trisacchar-
ide building blocks.
Experimental Section
General : Thin-layer chromatography (TLC) was carried out on pre-
coated 60 F254 silica gel alumina plates (Merck) using UV light and/
or 8% H2SO4 and/or AMC-solution (ammonium molybdate, cerium
(IV) sulphate, 10% H2SO4 [5:0.1:100, w/w/v] for visualisation. Flash
column chromatography was performed on silica gel (Merck, pore
size 60 æ, particle size 40–63 mm). NMR spectra were recorded in
CDCl3 (internal Me4Si d=0.00 ppm) at 25 8C on a Varian instrument
(500 MHz for 1H and 125 MHz for 13C or 600 MHz for 1H and
150 MHz for 13C, VNMRS 500 MHz or 600 MHz, Palo Alto, USA). Cou-
pling constants are given in Hertz (Hz). High-resolution mass spec-
trometry (HRMS) spectra were recorded on a Micromass LCT instru-
ment (Waters, Milford, USA) using electrospray ionisation (ESI) in
either the positive or negative modes. Optical rotations were mea-
sured with a PerkinElmer 343 polarimeter (Waltham, USA) at the
sodium D-line (589 nm) at 20 8C using a 1 dm cell. All reactions
containing air- and moisture-sensitive reagents were carried out
under an Ar atmosphere. Organic phases were dried over MgSO4
before evaporation, which was performed under reduced pressure
at temperatures not exceeding 40 8C.
Ethyl 2,3,4,6-tetra-O-benzoyl-b-d-glucopyranosyl-(1!2)-6-O-
benzyl-3-O-(2-naphthalenylmethyl)-1-thio-a-d-mannopyrano-
side (2). Sodium cyanoborohydride (223 mg, 3.56 mmol) was
added to a solution of acetal 1 (612 mg, 0.59 mmol) in dry tetrahy-
drofuran (THF, 25 mL) containing crushed molecular sieves (3 æ,
150 mg). A 1m solution of HCl in Et2O (9.0 mL, 9.0 mmol) was
added dropwise at 20 8C (until pH 1–2). The reaction mixture was
stirred until no starting material was detected by TLC (toluene/
EtOAc, 6:1). After 30 min, Et3N (2.5 mL, 17.80 mmol) was added, fol-
lowed by dropwise addition of MeOH (10 mL). CH2Cl2 (20 mL) was
added, the solids were removed by filtration through a short pad
of Celite, concentrated in vacuo, and then redissolved and co-
evaporated with MeOH (3Õ50 mL). Purification by flash column
chromatography (SiO2, 100 mL, 4.5 cm, toluene!toluene/EtOAc,
96:4!93:7!90:10!87:13!85:15!80:20!75:25) gave 2
(571 mg, 93%) as a colourless, amorphous solid: Rf=0.32 (toluene/
EtOAc, 6:1) ; [a]D
20+6.7 (c 1.0, CHCl3) ;
1H NMR (500 MHz, CDCl3):
d=7.96–7.88 (m, 6H), 7.87–7.81 (m, 2H), 7.79–7.66 (m, 4H), 7.54–
7.38 (m, 7H), 7.36–7.32 (m, 2H), 7.31–7.14 (m, 11H), 5.93 (t, J 9.7,
1H), 5.70–5.61 (m, 1H), 5.27 (d, J 1.0, 1H), 5.01 (d, J 7.9, 1H), 4.91
(d, J 11.5, 1H), 4.65 (dd, J 3.1, J 12.1, 1H), 4.57 (d, J 11.5, 1H), 4.48
(dd, J 5.7, J 12.1, 1H), 4.32 (dd, J 1.7, J 2.9, 1H), 4.26 (s, 2H), 4.21–
4.15 (m, 1H), 3.96 (ddd, J 3.3, J 6.6, J 9.7, 1H), 3.81 (t, J 9.4, 1H),
Scheme 5. Reagents and conditions : a) DMTST, Et2O, DMTST, Et2O, 0 8C!20 8C, 3.5 h, 83%; b) DDQ, CH2Cl2/tBuOH (10:1), 20 8C, 1.5 h, 68%.
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3.68 (dd, J 3.1, J 9.2, 1H), 3.58 (dd, J 3.3, J 10.7, 1H), 3.27 (dd, J 6.6,
J 10.7, 1H), 2.55–2.38 (m, 3H), 1.15 ppm (t, J 7.4, 3H); 13C NMR
(125 MHz, CDCl3): d=166.2, 166.0, 165.3, 164.9, 138.5, 135.2, 133.6,
133.4, 133.3, 133.2, 133.2, 133.1, 130.0, 129.9, 129.9, 129.8, 129.7,
129.6, 129.0, 128.9, 128.6, 128.5, 128.4, 128.4, 128.3, 128.1, 127.8,
127.5, 127.5, 127.1, 126.2, 126.1, 126.0, 99.8, 81.2, 77.9, 75.5, 73.4,
73.0, 72.7, 71.9, 71.86, 70.9, 70.9, 69.9 68.1, 63.4, 25.4, 14.8; HRMS
(ESI): [M¢H]¢ m/z calcd for C60H55O14S: 1031.3313, found:
1031.3279; Anal. calcd for C60H55O14S: C 69.75, H 5.46, S 3.10,
found: C 69.43, H 5.43, S 3.28.
Ethyl 2,3,4,6-tetra-O-benzoyl-b-d-glucopyranosyl-(1!2)-[2,3,4-
tri-O-benzoyl-b-d-xylopyranosyl-(1!4)]-6-O-benzyl-3-O-(2-naph-
thalenylmethyl)-1-thio-a-d-mannopyranoside (4). A catalytic
amount of TMSOTf (20 mL, 11 mmol) was added to a solution of
donor 3[16] (88 mg, 0.145 mmol) and acceptor 2 (116 mg,
0.113 mmol) in dry CH2Cl2 (5 mL) containing crushed molecular
sieves (AW-300, 40 mg) kept at ¢78 8C in an atmosphere of nitro-
gen. The temperature was then allowed to rise to 20 8C overnight
(TLC, toluene-EtOAc, 6:1). The reaction mixture was neutralised
with Et3N (16 mL, 0.113 mmol), the solids were removed by filtra-
tion, and the filtrate was concentrated in vacuo to a yellowish
foam. Purification by flash column chromatography (SiO2, 100 mL,
4.5 cm, toluene!toluene/tOAc, 98:2!96:4!94:6 !92:8!
90:10!88:12!86:14) gave 4 (118 mg, 70%) as a colourless foam:
Rf=0.46 (toluene/EtOAc, 9:1) ; [a]D
20+5.6 (c 1.0, CHCl3) ;
1H NMR
(500 MHz, CDCl3): d=7.93–7.83 (m, 14H), 7.77–7.69 (m, 4H), 7.56–
7.42 (m, 7H), 7.39–7.19 (m, 20H), 7.10–7.03 (m, 2H), 5.90 (t, J
9.7 Hz, 1H), 5.71–5.62 (m, 2H), 5.53 (t, J 8.2 Hz, 1H), 5.26 (dd, J
6.5 Hz, J 8.2 Hz, 1H), 5.20 (d, J 2.9 Hz, 1H), 5.16 (td, J 4.9 Hz, J
8.1 Hz, 1H), 5.02 (d, J 7.9 Hz, 1H), 4.94 (d, J 11.3 Hz, 1H), 4.73 (d, J
6.2 Hz, 1H), 4.68 (d, J 11.4 Hz, 1H), 4.61 (dd, J 3.1 Hz, J 12.1 Hz, 1H),
4.44 (dd, J 5.2 Hz, J 12.1 Hz, 1H), 4.20 (bs, 1H), 4.15–4.09 (m, 3H),
4.01–3.88 (m, 4H), 3.34 (dd, J 1.9 Hz, J 10.8 Hz, 1H), 3.27 (dd, J
5.9 Hz, J 10.9 Hz, 1H), 3.02 (dd, J 8.3 Hz, J 12.1 Hz, 1H), 2.44–2.30
(m, 2H), 1.06 ppm (t, J 7.4 Hz, 1H); 13C NMR (125 MHz, CDCl3): d=
166.1, 165.9, 165.5, 165.5, 165.3, 165.2, 164.9, 138.6, 135.6, 133.5,
133.4, 133.3, 133.3, 133.3, 133.2, 133.1, 133.0, 130.0, 130.0, 129.9,
129.9, 129.9, 129.8, 129.7, 129.5, 129.4, 129.4, 129.0, 128.9, 128.5,
128.5, 128.5, 128.4, 128.4, 128.2, 128.2, 128.0, 127.8, 127.5, 127.4,
127.2, 126.6, 126.1, 125.9, 100.8, 100.6, 81.3, 77.3, 77.1, 76.2, 73.1,
72.9, 72.6, 72.2, 71.9, 71.5, 71.4 (2C), 69.8, 69.5, 69.3, 63.3, 61.9,
25.2, 14.7 ppm; HRMS (ESI): [M+Na]+ m/z calcd for C86H76O21NaS:
1499.4498, found: 1499.4547; Anal. calcd for C86H76O21S: C 69.91, H
5.18, S 2.17, found: C 69.75, H 5.28, S 2.43.
Ethyl b-d-glucopyranosyl-(1!2)-[b-d-xylopyranosyl-(1!4)]-6-O-
benzyl-3-O-(2-naphthalenylmethyl)-1-thio-a-d-mannopyrano-
side (5). A catalytic amount of sodium methoxide (75 mg,
1.38 mmol) was added to a solution of 4 (4.10 g, 2.77 mmol) in dry
MeOH (150 mL). The mixture was stirred at 20 8C overnight (TLC,
CH2Cl2¢MeOH, 9:1). After complete conversion, Dowex (H+) acidic
ion-exchange resin was added for neutralisation, the resin was fil-
tered off, washed with MeOH (30 mL), and the filtrate was concen-
trated in vacuo. Purification by flash column chromatography (SiO2,
600 mL, 7.5 cm, DCM!DCM/MeOH, 95:5!90:10!88:12!
86:14!84:16!83:17!82:18) gave 5 (1.68 g, 80%) as a colourless,
amorphous solid: Rf=0.13 (CH2Cl2/MeOH, 9:1); [a]D
20+45.6 (c 1.0,
MeOH); 1H NMR (600 MHz, DMSO) d 7.93 (1H, s), 7.88–7.84 (1H, m),
7.81 (m, 2H), 7.56 (dd, 1.6 Hz, J 8.5 Hz, 1H), 7.48–7.43 (m, 2H),
7.43–7.28 (m, 4H), 7.27–7.23 (m, 1H), 5.40 (d, J 2.0 Hz, 1H), 5.10 (d,
J 4.8 Hz, 1H), 4.94–4.83 (m, 5H), 4.69–4.60 (m, 2H), 4.53 (d, J
11.9 Hz, 1H), 4.44 (d, J 11.9 Hz, 1H), 4.39 (t, J 5.6 Hz, 1H), 4.33 (d, J
7.8 Hz, 1H), 4.22 (d, J 7.4 Hz, 1H), 4.19 (t, J 2.8 Hz, 1H), 4.00–3.90
(m, 2H), 3.86 (dd, J 4.8 Hz, J 11.1 Hz, 1H), 3.75 (dd, J 1.6 Hz, J
11.2 Hz, 1H), 3.73–3.64 (m, 2H), 3.61 (dd, J 3.4 Hz, J 8.3 Hz, 1H),
3.42–3.35 (m, 1H), 3.32–3.27 (m, 1H), 3.19–3.09 (m, 2H), 3.09–2.96
(m, 4H), 2.88 (dd, J 10.2 Hz, J 11.5 Hz, 1H), 2.64–2.49 (m, 2H),
1.16 ppm (t, J 7.4 Hz, 3H); 13C NMR (125 MHz, DMSO): d=138.6,
136.6, 132.8, 132.4, 128.2, 127.6, 127.5, 127.4, 127.3, 126.2, 126.0,
125.9, 125.6, 103.9, 101.6, 81.8, 77.2, 76.8, 76.7, 76.6, 74.7, 74.1,
73.9, 73.1, 72.2, 71.7, 70.3, 70.3, 69.7, 68.8, 65.9, 61.5, 24.5,
14.9 ppm; HRMS (ESI): [M¢H]¢ m/z calcd for C37H47O14S: 747.2687,
found: 747.2702.
Ethyl 6-O-tert-butyldimethylsilyl-b-d-glucopyranosyl-(1!2)-[b-d-
xylopyranosyl-(1!4)]-6-O-benzyl-3-O-(2-naphthalenylmethyl)-1-
thio-a-d-mannopyranoside (6). tert-Butyldimethylchlorosilane
(82 mg, 0.55 mmol) and a catalytic amount of DMAP (1 mg,
8 mmol) were added to a solution of 5 (273 mg, 0.36 mmol) in dry
pyridine (10 mL), and the mixture was stirred at 20 8C for 4 h. The
progress of the reaction was followed by TLC (DCM/MeOH, 9:1).
The mixture was concentrated in vacuo, and then redissolved and
coevaporated with toluene (3Õ30 mL) (water bath temperature of
rotary evaporator: <30 8C). Purification by flash column chroma-
tography (SiO2, DCM!DCM/MeOH, 95:5!94:6!93:7!92:8!
91:9!90:10) gave 6 (240 mg, 76%) as colourless, amorphous
solid: Rf=0.35 (CH2Cl2/MeOH, 9:1) ; [a]D
20+31.5 (c 0.89, MeOH);
1H NMR (500 MHz, CDCl3): d=7.82–7.74 (m, 4H), 7.53 (d, J 8.5 Hz,
1H), 7.47–7.39 (m, 2H), 7.35–7.19 (m, 5H), 5.32 (s, 1H), 4.85 (d, J
11.5 Hz, 1H), 4.78 (d, J 11.5 Hz, 1H), 4.59 (d, J 12.0 Hz, 1H), 4.51 (d,
J 12.0 Hz, 1H), 4.43–4.36 (m, 2H), 4.31–4.19 (m, 3H), 4.13–4.07 (m,
2H), 3.93–3.77 (m, 6H), 3.73–3.64 (m, 3H), 3.55–3.40 (m, 4H), 3.35–
3.26 (m, 3H), 3.00 (t, J 10.6 Hz, 1H), 2.89 (bs, 1H), 2.61–2.46 (m,
2H), 1.20 (t, J 7.4 Hz, 1H), 0.84 (s, 9H), 0.00 (s, 3H), 0.00 ppm (s,
3H); 13C NMR (125 MHz, CDCl3): d=137.6, 134.8, 133.3, 133.2,
128.6, 128.2, 128.2, 128.1, 128.0, 127.8, 127.7, 126.7, 126.2, 126.1,
103.2, 100.7, 82.6, 77.0, 76.3, 76.1, 75.6, 74.2, 74.0, 73.7, 73.5, 72.3,
72.2, 72.0, 71.5, 69.7, 68.7, 65.6, 64.3, 25.9, 25.6, 18.3, 15.0, ¢5.3,
¢5.4 ppm; HRMS (ESI): [M¢H]¢ m/z calcd for C43H61O14SSi :
861.3551, found: 861.3558
Ethyl 2,3,4-tri-O-benzyl-6-O-tert-butyldimethylsilyl-b-d-glucopyr-
anosyl-(1!2)-[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!4)]-6-O-
benzyl-3-O-(2-naphthalenylmethyl)-1-thio-a-d-mannopyrano-
side (7). NaH (100 mg, 2.49 mmol, 60% oil dispersion) was washed
with pentane (3Õ10 mL) prior to use. NaH was added portionwise
to a solution of 6 (239 mg, 0.27 mmol) in dry DMF (10 mL) at 0 8C
in an atmosphere of nitrogen. After 15 min, benzyl bromide
(236 mL, 2.00 mmol) was added dropwise at 0 8C under vigorous
stirring. The temperature was then allowed to rise to 20 8C over-
night (TLC, toluene/EtOAc, 9:1). After complete consumption of
the starting material, residual NaH was quenched with MeOH
(1 mL), and then with H2O (50 mL). The resulting mixture was ex-
tracted once with EtOAc (40 mL), the layers were separated, and
the organic layer was washed with brine (1Õ40 mL), dried over
MgSO4, and concentrated in vacuo. Purification by flash column
chromatography (SiO2, toluene!toluene/EtOAc, 97:3!94:6!
92:8!91:9) gave 7 (300 mg, 77%) as a colourless syrup. Rf=0.61
(toluene/EtOAc, 9:1) ; [a]D
20+29.3 (c 1.0, CHCl3) ;
1H NMR (500 MHz,
CDCl3): d=7.89 (s, 1H), 7.85–7.74 (m, 3H), 7.62 (d, J 9.7 Hz, 1H),
7.49–7.13 (m, 35H), 7.10–7.02 (m, 2H), 5.47 (d, J 2.1 Hz, 1H), 5.14
(d, J 10.4 Hz, 1H), 5.06 (d, J 12.4 Hz, 1H), 4.94 (d, J 11.0 Hz, 1H),
4.87–4.69 (m, 7H), 4.66 (m, 2H), 4.57–4.50 (m, 3H), 4.38–4.22 (m,
5H), 4.08–4.02 (m, 1H), 3.92–3.75 (m, 5H), 3.68–3.51 (m, 5H), 3.43
(t, J 8.9 Hz, 1H), 3.37–3.28 (m, 2H), 2.90 (dd, J 10.1 Hz, J 11.6 Hz,
1H), 2.68–2.54 (m, 2H), 1.26 (t, J 7.4 Hz, 3H), 0.85 (s, 9H), 0.01 (s,
3H), 0.00 ppm (s, 3H); 13C NMR (126 MHz, CDCl3): d=138.9, 138.8,
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138.8, 138.7, 138.4, 138.4, 138.3, 136.3, 133.4, 133.0, 129.1, 129.0,
128.5, 128.4, 128.4, 128.2, 128.2, 128.2, 128.0, 128.0, 127.9, 127.8,
127.8, 127.8, 127.7, 127.6, 127.6, 127.5, 127.4, 126.8, 126.6, 125.9,
125.6, 103.4, 102.0, 85.0, 84.1, 82.4, 81.8, 78.3, 77.5, 76.4, 76.3, 75.7,
75.5, 75.4, 75.0, 75.0, 74.9, 74.6, 73.0, 72.9, 71.9, 71.1, 69.0, 63.6,
62.7, 26.2, 26.1, 25.5, 18.4, 15.0, ¢5.1, ¢5.2 ppm; HRMS (ESI): [M+
Na]+ m/z calcd for C85H98O14NaSSi: 1425.6344, found: 1425.6320.
Ethyl 2,3,4-tri-O-benzyl-b-d-glucopyranosyl-(1!2)-[2,3,4-tri-O-
benzyl-b-d-xylopyranosyl-(1!4)]-6-O-benzyl-3-O-(2-naphthale-
nylmethyl)-1-thio-a-d-mannopyranoside (8). TBAF trihydrate
(52 mg, 0.16 mmol) was added to a solution of 7 (153 mg,
0.11 mmol) in THF (5 mL), and the mixture was stirred at 20 8C for
2 h (TLC, toluene/EtOAc, 9:1). After complete consumption of the
starting material, the reaction mixture was concentrated in vacuo.
Purification by flash column chromatography (SiO2, toluene!tolu-
ene/EtOAc, 93:7!90:10!87:13!84:16!81:19!78:22!75:25)
gave 8 (135 mg, 96%) as a colourless, amorphous solid: Rf=0.39
(toluene/EtOAc, 6:1) ; [a]D
20+34.5 (c 0.42, CHCl3) ;
1H NMR (500 MHz,
CDCl3): d=7.84–7.77 (m, 4H, Har), 7.56–7.54 (m, 1H, Har), 7.48–7.44
(m, 2H, Har), 7.38–7.36 (m, 2H, Har), 7.32–7.20 (m, 31H, Har), 7.12–
7.11 (m, 2H, Har), 5.37 (d, 1H, J 3.4 Hz, H-1), 5.09 (d, 1H, J 10.4 Hz,
PhCH2), 4.93 (d, 1H, J 11.1 Hz, PhCH2), 4.90–4.84 (ABq, 2H, PhCH2),
4.82–4.70 (m, 6H, PhCH2), 4.63–4.50 (m, 5H, H-1’, PhCH2), 4.35–4.26
(m, 3H, H-1’’, PhCH2), 4.17 (m, 1H, H-4), 4.09 (m, 1H, H-2), 4.04–
4.02 (m, 1H, H-5), 3.92 (m, 1H, H-3), 3.78–3.73 (m, 3H, H-6a, H-6’a,
H-5’’a), 3.63–3.49 (m, 5H, H-6b, H-2’, H-3’, H-6’b, H-4’’), 3.43–3.39
(m, 2H, H-4’, H-3’’), 3.33–3.29 (m, 1H, H-5’), 3.27 ( t, 1H, J 8.4 Hz, H-
2’’), 2.86–2.80 (m, 1H, H-5’’b), 2.69–2.56 (m, 2H, SCH2CH3),
1.26 ppm (t, 3H, J 7.4 Hz, SCH2CH3) ;
13C NMR (125 MHz, CDCl3): d
138.7, 138.7, 138.5, 138.5, 138.3 (2C), 138.0, 136.1, 133.2, 133.0
(Car,quart), 128.8, 128.44, 128.40, 128.33, 128.28, 128.22, 128.21,
128.17, 128.1, 128.0, 127.9, 127.83, 127.78, 127.76, 127.7, 127.6,
127.51, 127.47, 127.4, 126.7, 126.1, 125.8 (Car), 104.1 (C-1’’), 103.2
(C-1’), 84.5 (C-3’), 84.0 (C-3’’), 82.2 (2C, C-1, C-2’’), 81.7 (C-2’), 78.0
(C-4’’), 77.8 (C-2), 77.6 (C-4’), 77.0 (C-3), 75.6 (PhCH2), 75.4 (PhCH2),
75.4 (C-5’), 75.1 (PhCH2), 75.0 (PhCH2), 74.8 (PhCH2), 73.0 (PhCH2),
73.0 (PhCH2), 72.4 (NapCH2), 72.0 (C-5), 69.0 (C-6), 63.6 (C-5’’), 62.2
(C-6’), 25.4 (SCH2CH3), 15.0 ppm (SCH2CH3). The signal of C-4 could
not be observed; HRMS (ESI): [M+Na]+ m/z calcd for
C79H84O14NaS: 1311.5479, found: 1311.5487.
Ethyl (benzyl 2,3,4-tri-O-benzyl-b-d-glucopyranosyluronate)-(1!
2)-[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!4)]-6-O-benzyl-3-O-
(2-naphthalenylmethyl)-1-thio-a-d-mannopyranoside (9). TEMPO
(2 mg, 13 mmol) and BAIB (300 mg, 0.93 mmol) were added to a vig-
orously stirred solution of 8 (116 mg, 90 mmol) in CH2Cl2/H2O
(12 mL, 3:1), and the mixture was stirred at 20 8C for 4 h. The prog-
ress of the reaction was carefully monitored by TLC (toluene/
EtOAc, 9:1). The reaction was quenched by adding 10% aq.
Na2S2O3 solution (10 mL). The resulting mixture was extracted once
with EtOAc (20 mL), the layers were separated, and the organic
layer was washed with brine (1Õ10 mL), dried over MgSO4, and
concentrated in vacuo. Cs2CO3 (57 mg, 0.17 mmol) was added to
a solution of the crude in dry DMF (3 mL) at 20 8C. After 15 min,
benzyl bromide (22 mL, 0.18 mmol) was added dropwise at 0 8C.
The temperature was then allowed to rise to 20 8C over 16 h (TLC,
toluene/EtOAc 9:1). After complete consumption of the starting
material, water (10 mL) was added, and the resulting mixture was
extracted with Et2O (2Õ15 mL), the layers were separated, and the
organic layer was dried over MgSO4, and concentrated in vacuo.
Purification by flash column chromatography (SiO2, toluene!tolu-
ene-EtOAc, 70:30) gave 9 (75 mg, 60%) as a pale yellow syrup: Rf=
0.45 (toluene/EtOAc, 9:1); [a]D
20+31.7 (c 1.0, CHCl3) ;
1H NMR
(500 MHz, CDCl3): d=7.84–7.77 (m, 3H), 7.74 (d, J 8.4 Hz, 1H),
7.59–6.97 (m, 43H), 5.39 (s, 1H), 5.11 (d, J 10.1 Hz, 1H), 5.07–5.00
(m, 2H), 4.92–4.85 (m, 2H), 4.84–4.77 (m, 2H), 4.77–4.69 (m, 4H),
4.65–4.60 (m, 2H), 4.55–4.50 (m, 2H), 4.48–4.44 (m, 2H), 4.37 (d, J
7.5 Hz, 1H), 4.31–4.24 (m, 2H), 4.21 (s, 2H), 4.05 (dd, J 3.8 Hz, J
9.6 Hz, 1H), 3.94 (d, J 9.8 Hz, 1H), 3.88–3.74 (m, 4H), 3.67–3.53 (m,
4H), 3.43 (t, J 8.9 Hz, 1H), 3.33–3.29 (m, 1H), 2.92–2.87 (m, 1H),
2.65–2.54 (m, 2H), 1.25 ppm (t, J 7.4 Hz, 3H); 13C NMR (125 MHz,
CDCl3): d=168.1, 138.8, 138.8, 138.7, 138.5, 138.4, 138.3, 138.0,
136.2, 135.1, 133.4, 133.1, 129.3, 128.8, 128.6, 128.6, 128.5, 128.5,
128.4, 128.4, 128.3, 128.2, 128.1, 128.0, 128.0, 127.9, 127.9, 127.8,
127.8, 127.8, 127.7, 127.7, 127.5, 127.5, 127.4, 126.8, 126.6, 125.9,
125.7, 103.5, 102.8, 84.2, 84.1, 82.5, 82.0, 81.1, 79.0, 78.5, 76.6, 76.3,
75.8, 75.6, 75.2, 75.2, 75.1, 74.9, 74.4, 73.0, 73.0, 72.0, 71.5, 68.9,
67.4, 63.7, 25.7, 15.1 ppm; HRMS (ESI): [M+Na]+ m/z calcd for
C86H88O15NaS: 1415.5742, found: 1415.5712.
2-Azidoethyl (benzyl 2,3,4-tri-O-benzyl-b-d-glucopyranosyluro-
nate)-(1!2)-[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!4)]-6-O-
benzyl-3-O-(2-naphthalenylmethyl)-a-d-mannopyranosyl-(1!3)-
2,4,6-tri-O-benzyl-a-d-mannopyranoside (11). A mixture of 10
(10 mg, 19.3 mmol), 9 (40 mg, 29 mmol), and crushed molecular
sieves (4 æ, 20 mg) in dry Et2O (2 mL) was stirred at 20 8C for
30 min. The reaction mixture was cooled to 0 8C, freshly prepared
DMTST (15 mg, 60 mmol) was added, and the reaction mixture was
stirred at 0 8C for 30 min. The progress of the reaction was carefully
monitored by TLC (toluene/EtOAc, 9:1). The cooling bath was re-
moved and stirring was continued at 20 8C for 1 h. Et2O (5 mL) was
added, and the reaction was quenched with Et3N (50 mL) at 0 8C.
The solids were removed by filtration through a pad of Celite, and
the filtrate was concentrated in vacuo. Purification by flash column
chromatography (SiO2, toluene/EtOAc, 97:3!70:30) gave 11
(34 mg, 95%) as a colourless syrup: Rf=0.56 (toluene/EtOAc, 9:1);
[a]D
20+7.5 (c 1.0, CHCl3) ;
1H NMR (600 MHz, CDCl3): d=7.77 (s, 1H),
7.72–7.63 (m, 3H), 7.53 (d, J 8.4, Hz, 1H), 7.41–6.98 (m, 57H), 5.20
(d, J 1.7 Hz, 1H), 5.08 (d, J 10.5 Hz, 1H), 5.05–4.99 (m, 2H), 4.86–
4.76 (m, 4H), 4.76–4.34 (m, 16H), 4.30–4.15 (m, 4H), 4.11 (dd, J 9.5,
3.1 Hz, 1H), 4.06 (d, J 7.8 Hz, 1H), 4.01–3.89 (m, 3H), 3.90–3.39 (m,
15H), 3.34–3.26 (m, 3H), 3.22 (ddd, J 13.2, 6.1, 3.7 Hz, 1H),
2.93 ppm (dd, J 11.9, 9.8 Hz, 1H); 13C NMR (151 MHz, CDCl3): d=
168.2, 138.8, 138.8, 138.7, 138.7, 138.5, 138.4, 138.4, 138.4, 138.4,
138.4, 136.4, 135.2, 133.4, 133.0, 129.2, 128.8, 128.7, 128.6, 128.5,
128.5, 128.4, 128.4, 128.4, 128.3, 128.2, 128.2, 128.1, 128.0, 127.9,
127.8, 127.8, 127.8, 127.7, 127.6, 127.6, 127.6, 127.6, 127.5, 127.4,
127.3, 126.9, 126.8, 126.8, 125.9, 125.7, 103.7 (JC¢H 161 Hz), 103.2
(JC¢H 162.5 Hz), 99.7 (JC¢H 172 Hz), 98.0 (JC¢H 171.5 Hz), 84.2, 83.6,
82.6, 81.0, 78.8, 78.7, 78.5, 78.4, 75.7, 75.6, 75.6, 75.5, 75.0, 74.9,
74.8, 74.6, 74.6, 74.6, 74.1, 73.5, 73.2, 73.0, 72.8, 72.7, 72.4, 72.0,
69.1, 67.3, 66.7, 63.7, 50.5 ppm; HRMS (ESI): [M+Na]+ m/z calcd for
C113H115O21N3Na: 1872.7921, found: 1872.7861.
2-Azidoethyl (benzyl 2,3,4-tri-O-benzyl-b-d-glucopyranosyluro-
nate)-(1!2)-[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!4)]-6-O-
benzyl-a-d-mannopyranosyl-(1!3)-2,4,6-tri-O-benzyl-a-d-man-
nopyranoside (12). DDQ (10 mg, 44 mmol) was added to a vigo-
rously stirred solution of 11 (34 mg, 18 mmol) in CH2Cl2/tBuOH
(4.4 mL, 10:1) at 20 8C. The progress of the reaction was monitored
by TLC (toluene/EtOAc, 9:1). After 60 min, the reaction was
quenched by adding satd. NaHCO3 solution (15 mL). The resulting
mixture was extracted once with CH2Cl2 (20 mL), the layers were
separated, and the organic layer was washed with, 10% aq.
Na2S2O3 solution (1Õ15 mL), dried over MgSO4, and concentrated
in vacuo to a yellow oil. Purification by flash column chromatogra-
phy (SiO2, toluene!toluene/EtOAc, 97:3!70:30) gave 12 (23 mg,
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74%) as a colourless syrup: Rf=0.24 (toluene/EtOAc, 9:1) ; [a]D
20+
10.2 (c 1.0, CHCl3) ;
1H NMR (600 MHz, CDCl3): d=7.51–6.92 (m,
55H), 5.22 (d, J 1.6 Hz, 1H), 5.11 (s, 2H), 5.03 (d, J 10.6 Hz, 1H),
4.85–4.76 (m, 4H), 4.74–4.70 (m, 2H), 4.69–4.56 (m, 8H), 4.52–4.48
(m, 2H), 4.44 (d, J 10.6 Hz, 1H), 4.39 (d, J 11.0 Hz, 1H), 4.25 (d, J
7.8 Hz,1H), 4.18 (d, J 11.8 Hz, 1H), 4.15–4.11 (m, 2H), 4.06 (dt, J 9.2,
3.8 Hz, 1H), 4.04–4.00 (m, 2H), 3.99–3.88 (m, 5H), 3.83 (ddd, J 10.1,
6.0, 3.6 Hz, 1H), 3.76 (ddd, J 9.9, 4.9, 1.9 Hz, 1H), 3.74–3.68 (m, 2H),
3.68–3.59 (m, 5H), 3.53 (ddd, J 10.7, 7.0, 3.6 Hz, 1H), 3.47 (t, J
9.1 Hz, 1H), 3.44–3.40 (m, 2H), 3.36–3.28 (m, 3H), 3.24 (ddd, J 13.2,
6.1, 3.7 Hz, 1H), 3.13 ppm (t, J 11.1 Hz, 1H); 13C NMR (151 MHz,
CDCl3): d=168.2, 138.7, 138.6, 138.6, 138.4, 138.4, 138.3, 138.3,
138.2, 138.2, 135.3, 129.0, 128.7, 128.7, 128.6, 128.6, 128.5, 128.5,
128.4, 128.4, 128.4, 128.3, 128.3, 128.2, 128.1, 128.1, 128.0, 128.0,
127.8, 127.8, 127.8, 127.7, 127.7, 127.7, 127.6, 127.6, 127.6, 127.4,
127.1, 126.8, 104.0, 103.1, 100.1, 97.9, 84.1, 83.5, 81.9, a80.9, 79.4,
79.0, 78.3 (2C), 78.0, 77.9, 75.8, 75.7, 75.2, 74.9, 74.8, 74.8, 74.5,
74.4, 73.5, 73.5, 73.1, 72.6, 72.5, 72.0, 69.1, 68.9, 68.5, 67.3, 66.8,
64.3, 50.5 ppm. HRMS (ESI): [M+Na]+ m/z calcd for
C102H107O21N3Na: 1732.7205, found: 1732.7264.
2-Azidoethyl 2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)-6-O-
acetyl-4-O-benzyl-3-O-(2-naphthalenylmethyl)-a-d-mannopyra-
nosyl-(1!3)-[benzyl 2,3,4-tri-O-benzyl-b-d-glucopyranosyluro-
nate-(1!2)][2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!4)]-6-O-
benzyl-a-d-mannopyranosyl-(1!3)-2,4,6-tri-O-benzyl-a-d-man-
nopyranoside (14). A mixture of 12 (22 mg, 13 mmol), 13[9] (18 mg,
20 mmol), and crushed molecular sieves (4 æ, 20 mg) in dry Et2O
(3 mL) was stirred at 20 8C for 30 min. The reaction mixture was
cooled to 0 8C, freshly prepared DMTST (14 mg, 56 mmol) was
added, and the reaction mixture was stirred at 0 8C for 30 min. The
progress of the reaction was carefully monitored by TLC (toluene/
EtOAc, 9:1). The cooling bath was removed, and stirring was con-
tinued at 20 8C for 1 h. Et2O (6 mL) was added and the reaction
was quenched with Et3N (40 mL, 0.20 mmol) at 0 8C. The solids
were removed by filtration through a pad of Celite, and the filtrate
was concentrated in vacuo. Purification by flash column chroma-
tography (SiO2, toluene!toluene/EtOAc, 95:5!60:40) gave 14
(26 mg, 79%) as a colourless syrup: Rf=0.47 (toluene/EtOAc, 9:1);
[a]D
20 ¢4.2 (c 1.0, CHCl3) ; 1H NMR (600 MHz, CDCl3): d=7.95 (s, 1H),
7.82–7.74 (m, 3H), 7.64 (dd, J 8.3, 1.5 Hz, 1H), 7.48 ¢6.91 (m, 78H),
5.64 (d, J 1.4 Hz, 1H), 5.25 (s, 1H), 5.13 (d, J 10.4 Hz, 1H), 5.08 (m,
2H), 4.99 (m, 2H), 4.87 (d, J 10.9 Hz, 1H), 4.85–4.72 (m, 5H), 4.72–
4.44 (m, 18H), 4.41–4.34 (m, 4H), 4.33–4.20 (m, 6H), 4.20–4.15 (m,
2H), 4.13–4.08 (m, 1H), 4.06 (d, J 7.5 Hz, 1H), 4.03–3.81 (m, 10H),
3.78–3.71 (m, 2H), 3.71–3.60 (m, 6H), 3.59–3.53 (m, 2H), 3.49 (t, J
8.5 Hz, 1H), 3.43–3.33 (m, 3H), 3.28–3.24 (m, 2H), 3.24–3.15 (m,
2H), 2.96 (t, J 11.3 Hz, 1H), 1.63 ppm (s, 3H); 13C NMR (151 MHz,
CDCl3): d=170.9, 168.2, 139.0, 138.9, 138.8, 138.8, 138.8, 138.7,
138.6, 138.6, 138.4, 138.2, 138.2 (3C), 138.1, 136.7, 135.5, 133.5,
133.1, 129.2, 128.8, 128.8, 128.5, 128.5, 128.5, 128.4, 128.4, 128.3,
128.3, 128.2, 128.2, 128.1, 127.9, 127.9, 127.8, 127.8, 127.8, 127.8,
127.7, 127.7, 127.7, 127.6, 127.6, 127.5, 127.4, 127.4, 127.3, 127.3,
127.1, 127.1, 126.7, 125.9, 125.8, 104.3 (JC¢H 161 Hz), 103.7 (JC¢H
162 Hz), 102.9 (JC¢H 159.5 Hz), 100.1 (JC¢H 171.6 Hz), 99.6 (JC¢H
176.4 Hz), 98.0 (JC¢H 169.8 Hz), 84.1, 84.0, 83.5, 82.6, 81.1, 81.0, 79.5,
79.2, 79.2, 79.1, 79.0, 78.4, 78.0, 75.7, 75.6, 75.5, 75.5, 75.4, 75.0,
75.0, 74.9, 74.7, 74.7, 74.6, 74.5, 74.4, 74.3, 73.7, 73.6, 73.3, 73.1,
73.0, 72.5, 72.5, 72.0, 71.7, 70.6, 69.1, 68.2, 67.2, 66.9, 64.3, 64.1,
64.0, 50.5, 20.8 ppm; HRMS (ESI): [M+Na]+ m/z calcd for
C154H159O31N3Na: 2569.0855, found: 2569.0840.
2-Aminoethyl b-d-xylopyranosyl-(1!2)-6-O-acetyl-a-d-manno-
pyranosyl-(1!3)-[ b-d-glucopyranosyluronate-(1!2)][ b-d-xylo-
pyranosyl-(1!4)]-a-d-mannopyranosyl-(1!3)-a-d mannopyra-
noside (15). 10% w Pd/C (17 mg, 16.1 mmol) was added to a solu-
tion of compound 14 (26 mg, 12.4 mmol) in AcOEt/H2O/AcOH
(4:2:1, 1.75 mL). The mixture was hydrogenolysed in a high-pres-
sure reactor (Berghof, Eningen, Germany) at 20 8C (p=30 bar).
After 48 h, the solids were removed by filtration using a ‘sandwich
filter’ (3 frits stacked on top of each other in the following order:
20 mm, 10 mm, 5 mm), rinsed with H2O (3Õ2 mL) and EtOH (3Õ
2 mL), and the filtrate was concentrated in vacuo. Purification by
reversed-phase chromatography (C-18, H2O/MeOH, 9:1!8:2!
7:3!6:4!2:8!0:10), followed by freeze-drying gave 15 (7.0 mg,
67%) as a colourless, amorphous solid; [a]20D+6.0 (c 0.40, H2O);
1H NMR (500 MHz, D2O): d=5.25 (s, 1H), 5.17 (s, 1H), 4.90 (s, 1H),
4.47 (d, J 7.8 Hz, 1H), 4.40 (d, J 7.8 Hz, 1H), 4.37–4.33 (m, 2H), 4.31
(d, J 7.8 Hz, 1H), 4.26–4.12 (m, 5H), 4.11–3.86 (m, 10H), 3.84–3.57
(m, 10H), 3.54–3.20 (m, 9H), 2.17 ppm (s, 3H); 13C anomeric signals
taken from Heteronuclear Single Quantum Coherence (HSQC) spec-
troscopy: 103.7, 102.8, 101.7, 100.9, 99.8, 99.6 ppm; HRMS (ESI):
[M+Na]+ m/z calcd for C38H63O31NNa: 1052.3282, found:
1052.3330.
2-Azidoethyl 4,6-O-benzylidene-3-O-(2-naphthalenylmethyl)-a-d-
mannopyranoside (17). A solution 16 (10.0 g, 29.6 mmol) and di-
butyltin oxide (9.96 g, 40.0 mmol) in anhydrous toluene (320 mL)
was heated at reflux with continuous removal of water (Dean–
Stark trap). After 3 h, the mixture was concentrated to half volume,
tetrabutylammonium iodide (14.8 g, 40.0 mmol) and 2-(bromome-
thyl)naphthalene (7.21 g, 32.6 mmol) were added, and the reaction
mixture was brought to reflux for another 3 h. To the reaction mix-
ture, EtOAc (400 mL) was added, and the organic layer was then
washed sequentially with water (3Õ200 mL), 10% aq. KF-solution
(3Õ200 mL), and brine (2Õ200 mL), dried over MgSO4, and concen-
trated in vacuo to a yellow oily residue. Purification by flash
column chromatography (SiO2, pentane!pentane/Et2O, 50:50!
35:65!25:75!15:85) gave 17 (12.5 g, 88%) as a pale yellow
syrup: Rf=0.33 (toluene/EtOAc, 3:1) ; [a]D
20+28.0 (c 1.0, CHCl3) ;
1H NMR (500 MHz, CDCl3): d=7.85–7.36 (m, 12H), 5.63 (s, 1H), 4.99
(d, J 12.0 Hz, 1H), 4.91 (d, J 1.5 Hz,1H), 4.90 (d, J 12.0 Hz, 1H), 4.30–
4.24 (m, 1H, H-6a), 4.16–4.12 (m, 2H), 3.99 (dd, J 3.0 Hz, J 9.0 Hz,
1H), 3.89–3.83 (m, 3H), 3.60 (ddd, J 3.7 Hz, J 6.8 Hz, J 10.6 Hz, 1H),
3.42–3.32 (m, 2H,), 2.74 ppm (d, J 1.5 Hz, 1H); 13C NMR (125 MHz,
CDCl3): d=137.7, 135.5, 133.4, 133.2, 129.1, 128.4, 128.4, 128.1,
127.8, 126.8, 126.3, 126.3, 126.1, 125.9, 101.9, 100.4, 78.8, 75.6, 73.2,
69.9, 69.0, 66.9, 63.9, 50.5 ppm; HRMS (ESI): [M+H]+ m/z calcd for
C26H28N3O6 : 478.1978, found: 478.1972.
2-Azidoethyl 2,3,4-tri-O-benzoyl-b-d-xylopyranosyl-(1!2)-4,6-O-
benzylidene-3-O-(2-naphthalenylmethyl)-a-d-mannopyrano-
side (18). A catalytic amount of TBDMSOTf (335 mL, 1.46 mmol)
was added to a solution of 3[16] (8.89 g, 14.66 mmol) and 17
(7.00 g, 14.66 mmol) in dry CH2Cl2 (125 mL) containing crushed mo-
lecular sieves (AW-300, 180 mg) kept at ¢78 8C in an atmosphere
of nitrogen. The temperature was then allowed to rise to 20 8C
overnight (TLC, toluene/EtOAc, 6:1). The reaction mixture was neu-
tralised with Et3N (1.23 mL, 8.79 mmol), the solids were removed
by filtration, and the filtrate was concentrated in vacuo to a yellow-
ish foam. Purification by flash column chromatography (SiO2, tolu-
ene!toluene/EtOAc, 98:2!96:4!94:6!92:8!90:10!88:12!
86:14) gave 18 (11.70 g, 86%) as a colourless, amorphous solid:
Rf=0.42 (toluene/EtOAc, 9:1) ; [a]D
20 ¢48.8 (c 1.0, CHCl3) ; 1H NMR
(500 MHz, CDCl3): d=8.23–8.22 (m, 2H), 8.08–8.07 (m, 2H), 7.97–
7.95 (m, 2H), 7.87 (m, 1H), 7.81–7.78 (m, 2H), 7.71–7.69 (m, 1H),
7.58–7.36 (m, 15H), 7.27–7.24 (m, 2H), 5.61 (t, J 4.2 Hz, 1H), 5.35–
5.32 (m, 1H), 5.15 (d, J 3.0 Hz, 1H), 5.11 (s, 1H), 5.10 (d, J 2.4 Hz,
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1H), 5.06–4.98 (ABq, 2H), 4.95 (dd, J 13.0 Hz, J 1.6 Hz, 1H), 4.87 (d,
J 1.6 Hz, 1H), 4.30 (dd, J 3.4 Hz, J 1.6 Hz 1H), 4.10–4.05 (m, 2H),
3.99 (t, J 9.5 Hz, 1H), 3.82–3.76 (m, 2H), 3.75–3.70 (m, 1H), 3.55–
3.50 (m, 1H), 3.48 (t, 1H, J 10.5 Hz), 3.37–2.27 ppm (m, 2H);
13C NMR (125 MHz, CDCl3): d=165.8, 165.5, 165.1, 137.9, 136.1,
133.7, 133.6, 133.2, 130.6, 130.3, 130.2, 129.8, 129.6, 129.5, 129.2,
128.7, 128.6, 128.5, 128.3, 128.2, 127.9, 126.5, 126.4, 126.3, 126.0,
125.9, 101.7, 98.4, 96.8, 78.7, 75.0, 74.7, 73.3, 68.9, 68.5, 68.1, 67.5,
67.0, 64.7, 59.6, 50.6 ppm; HRMS (ESI): [M+Na]+ m/z calcd for
C52H47N3O13Na: 944.3007, found: 944.2960.
2-Azidoethyl b-d-xylopyranosyl-(1!2)-4,6-O-benzylidene-3-O-(2-
naphthalenylmethyl)-a-d-mannopyranoside (19). A catalytic
amount of sodium methoxide (68 mg, 1.27 mmol) was added to
a solution of 18 (11.70 g, 12.69 mmol) in dry MeOH (250 mL). The
mixture was swirled at 20 8C overnight (TLC, CH2Cl2/MeOH, 9:1).
After complete conversion, Dowex (H+) acidic ion exchange resin
was added for neutralisation, the resin was filtered off, washed
with MeOH (50 mL), and the filtrate was concentrated in vacuo. Pu-
rification by flash column chromatography (SiO2, DCM!DCM/
MeOH, 99:1!98:2!97:3!96:4!95:5) gave 19 (11.70 g, 86%) as
a colourless, amorphous solid: Rf=0.39 (DCM/MeOH, 9:1); [a]D
20
¢1.8 (c 1.0, CHCl3) ; 1H NMR (500 MHz, CDCl3): d=7.82–7.78 (m,
3H), 7.75–7.73 (m, 1H), 7.52–7.44 (m, 5H), 7.40–7.36 (m, 3H), 5.66
(s, 1H), 5.05 (d, J 11.7 Hz, 1H,), 4.88 (d, J 11.7 Hz, 1H,), 4.85 (d, J
1.5 Hz, 1H,), 4.53 (d, J 7.0 Hz, 1H,), 4.27–4.35 (m, 1H), 4.21–4.17 (m,
2H), 4.08 (dd, J 3.0 Hz, J 9.0 Hz, 1H,), 4.05–4.02 (m, 2H), 3.89–3.81
(m, 3H), 3.64–3.58 (m, 2H), 3.49–3.46 (m, 2H), 3.37 (m, 2H), 3.26
(dd, J 9.5 Hz. J 11.5 Hz, 1H,), 3.14 (s br, 1H), 2.67 ppm (s br, 1H);
13C NMR (125 MHz, CDCl3): d=137.4, 134.6, 133.2, 133.1, 129.0,
128.3, 128.0, 127.7, 127.4, 126.1, 101.7, 101.3, 100.0, 79.3, 74.8, 74.5,
74.5, 71.6, 69.8, 69.5, 68.7, 66.7, 65.3, 64.1, 50.4 ppm; HRMS (ESI):
[M+Na]+ m/z calcd for C31H35N3O10Na: 632.2220, found: 632.2195.
2-Azidoethyl 2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)-4,6-O-
benzylidene-3-O-(2-naphthalenylmethyl)-a-d-mannopyrano-
side (20). NaH (3.81 g, 95.61 mmol, 60% oil dispersion) was
washed with pentane (3Õ100 mL) prior to use. NaH was added
portionwise to a solution of 19 (12.96 g, 21.24 mmol) in dry DMF
(200 mL) kept at 0 8C under an atmosphere of nitrogen. After
15 min, benzyl bromide (10.09 mL, 84.96 mmol) was added drop-
wise at 0 8C under vigorous stirring. The temperature was then al-
lowed to rise to 20 8C over 3 h (TLC, toluene/EtOAc, 6:1). After
complete consumption of the starting material, residual NaH was
quenched with MeOH, and then with H2O (300 mL). The resulting
mixture was extracted once with EtOAc (600 mL), the layers were
separated, and the organic layer was washed with brine (1Õ
400 mL), dried over MgSO4, and concentrated in vacuo. Purification
by flash column chromatography (SiO2, toluene!toluene/EtOAc,
98:2!96:4!94:6!92:8!90:10!88:12) gave 20 (16.87 g, 90%)
as a colourless syrup: Rf=0.55 (toluene/EtOAc, 6:1) ; [a]D
20 ¢8.0 (c
1.0, CHCl3) ;
1H NMR (500 MHz, CDCl3): d=7.86 (m, 1H), 7.81–7.79
(m, 1H), 7.76–7.74 (m, 1H), 7.68–7.66 (m, 1H), 7.52–7.48 (m,
3H),7.44–7.42 (m, 2H), 7.39–7.27 (m, 18H), 5.61 (s, 1H), 4.98 (d, J
10.5 Hz, 1H), 4.95 (d, J 1.6 Hz, 1H),4.91–4.85 (m, 4H), 4.73–4.69 (m,
2H), 4.61 (d, J 11.6 Hz, 1H), 4.45 (d, J 7.2 Hz, 1H), 4.28 (m, 1H),
4.21–4.17 (m, 2H), 4.03–3.99 (m, 2H), 3.86–3.78 (m, 3H), 3.66 (ddd,
J 5.2 Hz, J 8.3 Hz, J 9.5 Hz, 1H), 3.59 (t, J 8.8 Hz, 1H), 3.56–3.49 (m,
2H), 3.35 (ddd, J 3.5 Hz, J 7.1 Hz, J 13.3 Hz, 1H,), 3.30–3.23 ppm (m,
2H); 13C NMR (125 MHz, CDCl3): d=138.7, 138.3, 138.1, 137.6,
136.0, 133.3, 132.9, 128.8, 128.5, 128.4, 128.3, 128.2, 127.9, 127.8,
127.6, 126.3, 126.1, 125.8, 125.6, 103.9, 101.6, 99.1, 83.8, 81.5, 78.4,
77.8, 76.2, 75.5, 75.1, 74.2, 73.3, 71.9, 68.9, 66.7, 64.6, 64.1,
50.3 ppm; HRMS (ESI): [M+Na]+ m/z calcd for C52H53N3O10Na:
902.3629, found: 902.3613.
2-Azidoethyl 2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)-4-O-
benzyl-3-O-(2-naphthalenylmethyl)-a-d-mannopyranoside (21).
A 1m solution of BH3 in THF (23.6 mL, 23.6 mmol) was added to
a solution of 20 (2.08 g, 2.36 mmol) in dry CH3CN (40 mL) kept at
0 8C under an atmosphere of nitrogen. After 5 min, a 1m solution
of Bu2BOTf (2.36 mL, 2.36 mmol) was added dropwise at 0 8C, and
the reaction mixture was stirred for 90 min (TLC, toluene-EtOAc,
6:1). After complete consumption of the starting material, the reac-
tion was quenched with Et3N (10 mL), followed by dropwise addi-
tion of MeOH (10 mL) at 0 8C. The mixture was concentrated in
vacuo, and the residue was redissolved and co-evaporated with
MeOH (3Õ50 mL). The syrupy residue was redissolved in MeOH,
the solids were removed by filtration through a short pad of Celite,
and the filtrate was concentrated in vacuo. Purification by flash
column chromatography (SiO2, toluene!toluene/EtOAc, 97:3!
94:6!91:9!88:12!85:15!82:18!79:21) gave 21 (1.59 g, 76%)
as a colourless syrup: Rf=0.16 (toluene/EtOAc, 6:1) ; [a]D
20+6.2 (c
1.0, CHCl3) ;
1H NMR (500 MHz, CDCl3): d=7.81–7.80 (m, 2H), 7.76–
7.74 (m, 1H), 7.71–7.69 (m, 1H), 7.52–7.50 (m, 1H), 7.47–7.43 (m,
2H), 7.37–7.26 (m, 20H), 5.01–4.98 (m, 2H), 4.94–4.92 (m, 2H), 4.86
(ABq, J 12.0 Hz, 2H), 4.76–4.70 (m, 3H), 4.62–4.59 (m, 2H), 4.42 (d, J
7.5 Hz, 1H), 4.16 (m, 1H), 4.00–3.97 (m, 2H), 3.90 (t, J 9.5 Hz, 1H),
3.82–3.76 (m, 2H), 3.72–3.63 (m, 3H), 3.58 (t, J 8.8 Hz, 1H), 3.54–
3.49 (m, 2H), 3.36–3.32 (ddd, 1H), 3.29–3.21 (m, 2H), 1.62 ppm (bs,
1H); 13C NMR (125 MHz, CDCl3): d=138.7, 138.6, 138.4, 138.1,
135.6, 133.3, 133.1, 128.5, 128.38, 128.37, 128.3, 127.99, 127.97,
127.94, 127.92, 127.89, 127.87, 127.8, 127.7, 127.6, 127.5, 127.1,
126.5, 125.9, 125.8, 103.8, 98.2, 83.9, 81.2, 78.1, 77.5, 75.5, 75.2, 74.8
(2C), 74.79, 74.4, 73.4, 72.4, 71.5, 66.6, 64.2, 62.5, 50.4 ppm; HRMS
(ESI): [M+Na]+ m/z calcd for C52H55N3O10Na: 904.3785, found:
904.3763.
2-Azidoethyl 2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)-6-O-
acetyl-4-O-benzyl-3-O-(2-naphthalenylmethyl)-a-d-mannopyra-
noside (22). Acetic anhydride (2.44 mL, 25.76 mmol) was added to
a solution of 21 (2.84 g, 1.47 mmol) in dry pyridine (50 mL) at
20 8C, and the mixture was stirred for 3 h (TLC, toluene/EtOAc, 9:1).
The reaction mixture was concentrated in vacuo, and then redis-
solved and co-evaporated with toluene (3Õ100 mL). Purification by
flash column chromatography (SiO2, toluene!toluene/EtOAc,
97:3!94:6!91:9!88:12!85:15) gave 22 (2.76 g, 93%) as a col-
ourless syrup: Rf=0.25 (toluene/EtOAc, 9:1) ; [a]D
20+11.0 (c 1.0,
CHCl3) ;
1H NMR (500 MHz, CDCl3): d=7.83–7.80 (m, 2H), 7.76 (m,
1H), 7.72–7.69 (m, 1H), 7.52 (m, 1H), 7.48–7.44 (m, 2H), 7.39–7.25
(m, 20H), 5.06 (d, J 10.0 Hz, 1H), 4.99 (d, J 11.5 Hz, 1H), 4.95–4.93
(m, 2H), 4.90–4.84 (m, 2H), 4.75–4.72 (m, 2H), 4.63–4.61 (m, 2H),
4.56 (d, J 11.0 Hz, 1H), 4.40 (d, J 7.0 Hz, 1H), 4.35–4.29 (m, 2H), 4.16
(m, 1H), 4.02–3.98 (m, 2H), 3.95 (t, J 9.5 Hz), 3.84–3.80 (m, 2H),
3.70–3.65 (m, 1H), 3.58–3.51 (m, 3H), 3.35 (ddd, J 3.5 Hz, J 7.1 Hz, J
13.3 Hz, 1H), 3.28 (ddd, J 3.0 Hz, J 6.0 Hz, J 9.8 Hz, 1H), 3.24 (t, J
11.0 Hz, 1H), 1.75 ppm (s, 3H); 13C NMR (125 MHz, CDCl3): d=
170.6, 138.8, 138.2, 138.1, 135.5, 133.3, 133.1, 128.8–125.8, 104.1,
98.2, 83.9, 81.4, 78.2, 77.4, 75.6, 75.2, 75.1, 75.0, 73.8, 73.4, 71.5,
70.2, 66.6, 64.2, 63.3, 50.4, 20.5 ppm; HRMS (ESI): [M+Na]+ m/z
calcd for C54H57N3O11Na: 946.3891, found: 946.3876.
2-Azidoethyl 2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)-4,6-di-
O-benzyl-3-O-(2-naphthalenylmethyl)-a-d-mannopyrano-
side (23). NaH (155 mg, 3.88 mmol, 60% oil dispersion) was
washed with pentane (3Õ10 mL) prior to use. NaH was added por-
tionwise to a solution of 21 (0.98 g, 1.11 mmol) in dry DMF (40 mL)
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kept at 0 8C under an atmosphere of nitrogen. After 15 min, benzyl
bromide (395 mL, 3.33 mmol) was added dropwise at 0 8C under
vigorous stirring. The temperature was then allowed to rise to
20 8C over 2 h (TLC, toluene/EtOAc, 6:1). After complete consump-
tion of the starting material, residual NaH was quenched with
MeOH (2 mL), and then with H2O (80 mL). The resulting mixture
was extracted once with EtOAc (160 mL), the layers were separat-
ed, and the organic layer was washed with brine (1Õ100 mL),
dried over MgSO4 and concentrated in vacuo. Purification by flash
column chromatography (SiO2, toluene!toluene/EtOAc, 98:2!
96:4!94:6!92:8!90:10) gave 23 (1.03 g, 95%) as a colourless
syrup: Rf=0.38 (toluene/EtOAc, 9:1) ; [a]D
20+7.8 (c 1.0, CHCl3) ;
1H NMR (500 MHz, CDCl3): d=7.82–7.80 (m, 2H, H), 7.75–7.73 (m,
1H), 7.70–7.68 (m, 1H), 7.52–7.50 (m, 1H), 7.47–7.15 (m, 27H), 5.06
(d, J 10.5 Hz, 1H), 4.95–4.92 (m, 3H), 4.90–4.82 (ABq, 2H), 4.75–4.71
(m, 2H), 4.61 (d, J 10.5 Hz, 1H), 4.55–4.52 (m, 2H), 4.42–4.40 (m,
3H), 4.15 (s, 1H), 4.03–3.96 (m, 3H), 3.84 (ddd, J 3.5 Hz, J 5.8 Hz, J
10.7 Hz, 1H), 3.81–3.77 (m, 1H), 3.75–3.64 (m, 3H), 3.57–3.49 (m,
3H), 3.35 (ddd, J 3.5 Hz, J 7.2 Hz, J 13.3 Hz, 1H), 3.29–3.21 ppm (m,
2H); 13C NMR (125 MHz, CDCl3): d=138.9, 138.6, 138.6, 138.3,
138.2, 135.7, 133.3, 133.1, 128.9, 128.5, 128.3, 128.2, 128.2, 128.0,
127.95, 127.92, 127.87, 127.64, 127.60, 127.54, 127.51, 127.47,
127.4, 127.1, 126.5, 125.9, 125.7, 104.1, 98.2, 84.0, 81.2, 78.3, 77.4,
75.5, 75.2 (2C), 75.0, 74.4, 73.4, 73.3, 72.1, 71.6, 69.5, 66.5, 64.2,
50.4 ppm; HRMS (ESI): [M+Na]+ m/z calcd for C59H61N3O10Na,:
994.4255, found: 994.4252.
2-Azidoethyl 2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)-6-O-
acetyl-4-O-benzyl-a-d-mannopyranoside (24). DDQ (393 mg,
1.73 mmol) was added to a vigorously stirred solution of 23
(1.00 g, 1.08 mmol) in CH2Cl2/H2O (44 mL, 10:1) at 20 8C. Additional
amounts of DDQ (295 mg, 1.30 mmol) were added after 20 min.
More DDQ (295 mg, 1.30 mmol) was added after 40 min. The prog-
ress of the reaction was carefully monitored by TLC (toluene/
EtOAc, 6:1). After 60 min, the reaction was quenched by adding
10% aq. Na2S2O3 solution (200 mL). The resulting mixture was ex-
tracted once with CH2Cl2 (200 mL), the layers were separated, and
the organic layer was washed sequentially with sat. NaHCO3 solu-
tion (3Õ150 mL), and brine (1Õ150 mL), dried over MgSO4, and
concentrated in vacuo. The residue was purified by flash column
chromatography (SiO2, toluene!toluene/EtOAc, 96:4!93:7!
90:10!87:13!84:16!80:20). The first fraction to appear in the
eluate contained recovered starting material (51 mg). Solvent re-
moval of the second and main fraction gave 24 (624 mg, 73%) as
a colourless syrup: Rf=0.26 (toluene/EtOAc, 6:1) ; [a]D
20+42.0 (c
1.0, CHCl3) ;
1H NMR (500 MHz, CDCl3): d=7.36–7.24 (m, 20H), 4.99
(d, J 11.0 Hz, 1H), 4.93–4.86 (m, 3H), 4.74–4.69 (m, 3H), 4.64–4.61
(m, 2H), 4.37 (dd, J 2.0 Hz, J 12.0 Hz, 1H), 4.34 (d, J 8.0 Hz, 1H),
4.27 (dd, J 4.5 Hz, J 12.0 Hz, 1H), 4.03 (td, J 3.4 Hz, J 9.2 Hz, 1H),
3.97–3.91 (m, 2H), 3.84–3.78 (m, 2H), 3.66–3.50 (m, 4H), 3.42–3.36
(m, 2H), 3.34–3.28 (m, 1H), 3.23 (dd, J 11.7 Hz, J 10.3 Hz, 1H,), 3.17
(d, J 9.5 Hz, 1H), 1.87 ppm (s, 3H); 13C NMR (125 MHz, CDCl3): d=
170.7, 138.6, 138.3, 138.0, 137.9, 128.6–127.7, 104.4, 98.4, 83.8, 81.5,
80.7, 77.6, 76.3, 75.9, 75.4, 75.0, 73.7, 71.0, 70.0, 66.7, 64.4, 63.6,
50.4, 20.7 ppm; HRMS (ESI): [M+Na]+ m/z calcd for C43H49N3O11Na:
806.3265, found: 806.3230; Anal. calcd for C43H49N3O11: C 65.89, H
6.30, N 5.36, found: C 65.70, H 6.27, N 5.31.
2-Azidoethyl 2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)-4,6-di-
O-benzyl-3-O-(2-naphthalenylmethyl)-a-d-mannopyranosyl-(1!
3)-[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)]-6-O-acetyl-4-O-
benzyl-a-d-mannopyranoside (26). A mixture of 24 (66 mg,
84.2 mmol), 25[9] (119 mg, 125.6 mmol), and crushed molecular
sieves (4 æ, 20 mg) in dry Et2O (6 mL) was stirred at 20 8C for
30 min. The reaction mixture was cooled to 0 8C, freshly prepared
DMTST (64 mg, 248 mmol) was added, and the reaction mixture
was stirred at 0 8C for 30 min. The progress of the reaction was
carefully monitored by TLC (toluene/EtOAc, 9:1). The cooling bath
was removed, and stirring was continued at 20 8C for 3 h. Et2O
(8 mL) was added and the reaction was quenched with Et3N
(200 mL) at 0 8C. The solids were removed by filtration through
a pad of Celite, and the filtrate was concentrated in vacuo. Purifica-
tion by flash column chromatography (SiO2, toluene/EtOAc, 95:5!
7:3) gave 26 (119 mg, 85%) as a colourless syrup: Rf=0.66 (tolu-
ene/EtOAc, 9:1) ; [a]D
20+3.5 (c 1.0, CHCl3) ;
1H NMR (500 MHz,
CDCl3): d=7.80 (m, 1H), 7.76–7.74 (m, 1H), 7.70–7.67 (m, 2H),
7.50–7.48 (m, 1H), 7.42–7.14 (m, 47H), 5.19 (s, 1H), 5.06 (d, J
11.0 Hz, 1H), 5.01 (d, J 12.0 Hz, 1H), 4.97 (d, J 10.5 Hz, 1H), 4.86–
4.76 (m, 7H), 4.69 (d, J 12.0 Hz, 1H), 4.64 (d, J 10.0 Hz, 1H), 4.58–
4.55 (m, 3H), 4.49 (d, J 11.0 Hz, 1H), 4.45 (d, J 12.0 Hz, 1H), 4.39 (d,
J 12.0 Hz, 2H), 4.34–4.20 (m, 6H), 4.12–4.08 (m, 3H), 3.98–3.93 (m,
4H), 3.84–3.68 (m, 6H), 3.58–3.53 (m, 1H), 3.50–3.36 (m, 5H), 3.33–
3.25 (m, 2H), 3.22–3.17 (m, 1H), 3.06 (t, J 10.8 Hz, 1H), 2.77 (t, J
10.8 Hz, 1H), 1.84 ppm (s, 3H); 13C NMR (125 MHz, CDCl3): d=
170.6, 139.3, 138.95, 138.9, 138.86, 138.6, 138.5, 138.4, 138.1, 138.0,
136.0, 133.3, 133.0, 128.9, 128.7, 128.6, 128.44, 128.37, 128.35,
128.33, 128.30, 128.28, 128.2, 128.1, 128.0, 127.90, 127.88, 127.85,
127.81, 127.79, 127.77, 127.75, 127.70, 127.6, 127.49, 127.47,
127.45, 127.42, 127.35, 127.1, 126.8, 126.6, 126.0, 125.8, 104.3,
103.7, 100.3 (JC¢1,H¢1 170 Hz), 98.4 (JC¢1,H¢1 175 Hz), 83.8, 83.4, 81.6,
81.0, 78.5 (2C), 77.7, 77.4, 77.1, 75.8, 75.6, 75.3, 75.12, 75.09, 74.9,
74.7, 74.4, 73.4, 73.2, 72.5 (2C), 72.2, 70.3, 69.9, 66.6, 63.9, 63.5,
63.2, 50.3, 20.7 ppm; HRMS (ESI): [M+Na]+ m/z calcd for
C100H105N3O20Na: 1690.7189, found: 1690.7153; Anal. calcd for
C100H105N3O20 : C 71.97, H 6.34, N 2.52, found: C 71.99, H 6.32, N
2.54.
2-Azidoethyl 2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)-4,6-di-
O-benzyl-a-d-mannopyranosyl-(1!3)-[2,3,4-tri-O-benzyl-b-d xy-
lopyranosyl-(1!2)]-6-O-acetyl-4-O-benzyl-a-d-mannopyrano-
side (27). DDQ (22 mg, 99 mmol) was added to a vigorously stirred
mixture of compound 26 (104 mg, 62 mmol) in CH2Cl2/H2O (11 mL,
10:1) at 20 8C. Additional amounts of DDQ (17 mg, 75 mmol) were
added after 20 min. More DDQ (17 mg, 75 mmol) was added after
40 min. The progress of the reaction was carefully monitored by
TLC (toluene/EtOAc, 6:1). After 60 min, the reaction was quenched
by adding 10% aq. Na2S2O3 solution (20 mL). The resulting mixture
was extracted once with CH2Cl2 (50 mL), the layers were separated,
and the organic layer was washed sequentially with sat. NaHCO3
solution (3Õ30 mL), and brine (1Õ30 mL), dried over MgSO4, and
concentrated in vacuo. The residue was purified by flash column
chromatography (SiO2, toluene!toluene/EtOAc, 96:4!93:7!
90:10 !87:13!84:16!81:19!78:22). The first fraction to appear
in the eluate contained recovered starting material (13 mg). Sol-
vent removal of the second and main fraction gave 27 (76 mg,
80%) as a colourless foam: Rf=0.25 (toluene/EtOAc, 6:1) ; [a]D
20+
13.6 (c 1.0, CHCl3) ;
1H NMR (500 MHz, CDCl3): d=7.38–7.13 (m,
45H), 5.19 (s, 1H), 4.99–4.94 (m, 2H), 4.94 (d, J 11.0 Hz, 1H), 4.88–
4.80 (m, 6H), 4.69 (d, J 11.5 Hz, 1H), 4.66–4.57 (m, 5H), 4.51 (s, 2H),
4.36–4.24 (m, 6H), 4.13–4.06 (m, 3H), 3.99 (dd, J 5.5 Hz, J 12.0 Hz,
1H), 3.90 (t, J 9.5 Hz, 1H), 3.85–3.83 (m, 2H), 3.80–3.68 (m, 5H),
3.60 (t, J 9.3 Hz, 1H), 3.57–3.49 (m, 2H), 3.46 (t, J 9.3 Hz, 1H), 3.44–
3.39 (m, 2H), 3.36 (t, J 9.0 Hz, 1H), 3.30–3.26 (m, 2H), 3.24–3.19 (m,
1H), 3.07–3.03 (m, 2H), 2.85 (t, J 11.3 Hz, 1H), 1.84 ppm (s, 3H);
13C NMR (125 MHz, CDCl3): d=170.6, 139.2, 138.8, 138.7, 138.4,
138.3, 138.20, 138.16, 138.0, 128.7, 128.64, 128.58, 128.4, 128.29,
128.28, 128.23, 128.20, 127.95, 127.85, 127.83, 127.79, 127.77,
127.74, 127.71, 127.64 127.56, 127.54, 127.50, 127.46, 127.44,
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127.36, 126.7, 104.4, 104.0, 100.9, 98.3, 83.8, 83.2, 81.4, 80.8, 80.7,
78.8, 77.7, 77.3, 77.1, 75.5, 75.5, 75.1, 74.7, 74.7, 74.6, 74.4, 73.4,
73.3, 72.6, 71.9, 70.8, 70.4, 69.8, 66.5, 63.9, 63.5, 63.1, 50.3,
20.6 ppm; HRMS (ESI): [M+Na]+ m/z calcd for C89H97N3O20Na:
1550.6563, found: 1550.6541.
2-Azidoethyl (benzyl 2,3,4-tri-O-benzyl-b-d-glucopyranosyluro-
nate)-(1!2)-[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!4)]-6-O-
benzyl-3-O-(2-naphthalenylmethyl)-a-d-mannopyranosyl-(1!3)-
[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)]-4,6-di-O-benzyl-a-
d-mannopyranosyl-(1!3)-[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-
(1!2)]-6-O-acetyl-4-O-benzyl-a-d-mannopyranoside (28). A mix-
ture of 27 (31 mg, 20.3 mmol), 9 (41 mg, 29.4 mmol), and crushed
molecular sieves (4 æ, 20 mg) in dry Et2O (3 mL) was stirred at 20 8C
for 30 min. The reaction mixture was cooled to 0 8C, freshly pre-
pared DMTST (22 mg, 88 mmol) was added, and the reaction mix-
ture was stirred at 0 8C for 30 min. The progress of the reaction
was carefully monitored by TLC (toluene/EtOAc, 9:1). The cooling
bath was removed, and stirring was continued at 20 8C for 3 h.
Et2O (8 mL) was added and the reaction was quenched with Et3N
(200 mL) at 0 8C. The solids were removed by filtration through
a pad of Celite, and the filtrate was concentrated in vacuo. Purifica-
tion by flash column chromatography (SiO2, toluene/EtOAc, 98:2!
80:20) gave 28 (48 mg, 83%) as a colourless syrup: Rf=0.44 (tolu-
ene/EtOAc, 9:1); [a]D
20 ¢18.9 (c 1.0, CHCl3) ; 1H NMR (500 MHz,
CDCl3): d=7.82–7.78 (m, 2H), 7.71 (d, J 8.1 Hz, 1H), 7.67 (d, J
8.4 Hz, 1H), 7.51 (d, J 8.4 Hz, 1H), 7.45–6.99 (m, 87H), 5.25 (s, 1H),
5.16 (s, 1H), 5.08–4.90 (m, 5H), 4.86–4.70 (m, 8H), 4.69–5.58 (m,
7H), 4.57–4.39 (m, 9H), 4.38–4.27 (m, 7H), 4.27–4.14 (m, 8H), 4.14–
3.98 (m, 8H), 3.88 (d, J 3.1 Hz, 1H), 3.84 (d, J 7.7 Hz, 1H), 3.83–3.58
(m, 9H), 3.58–3.34 (m, 11H), 3.32–3.14 (m, 4H), 3.13–3.04 (m, 2H),
2.95–2.83 (m, 2H), 1.78 ppm (s, 3H); 13C NMR (125 MHz, CDCl3): d=
170.8, 168.1, 139.0, 139.0, 138.9, 138.9, 138.8, 138.7, 138.7, 138.7,
138.6, 138.6, 138.6, 138.5, 138.4, 138.3, 138.2, 138.1, 136.3, 135.2,
133.3, 133.0, 129.2, 128.8, 128.8, 128.8, 128.7, 128.7, 128.6, 128.6,
128.5, 128.5, 128.4, 128.4, 128.4, 128.3, 128.3, 128.3, 128.2, 128.2,
128.1, 1278.0, 127.9, 127.8, 127.8, 127.8, 127.7, 127.6, 127.5, 127.5,
127.5, 127.4, 127.4, 127.4, 127.4, 127.3, 127.2, 127.2, 126.0, 125.9,
125.8, 104.5 (JC¢H 160 Hz), 103.8 (JC¢H 161.5 Hz), 103.6 (JC¢H
163.5 Hz), 102.8 (JC¢H 162.5 Hz), 101.3 (JC¢H 172.5 Hz), 99.4 (JC¢H
170 Hz), 98.4 (JC¢H 171.5 Hz), 84.4, 84.0, 83.4, 83.4, 82.6, 81.7, 81.5,
80.9, 79.5, 79.1, 78.8, 78.8, 78.6, 78.5, 78.2, 76.3 (2C), 75.6 (2C), 75.5
(2C), 75.3 (3C), 75.0 (2C), 74.8, 74.6, 74.5 (2C), 74.3, 73.7 (2C), 73.6,
73.2, 73.1, 72.8, 72.8, 72.6, 72.4, 71.9, 70.5, 69.7 (2C), 67.2, 66.6,
63.7, 63.6, 63.5, 63.4, 50.4, 20.7 ppm; HRMS (ESI): [M+Na]+ m/z
calcd for C173H179N3O35Na: 2881.2217, found: 2881.2205.
2-Azidoethyl (benzyl 2,3,4-tri-O-benzyl-b-d-glucopyranosyluro-
nate)-(1!2)-[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!4)]-6-O-
benzyl-a-d-mannopyranosyl-(1!3)-[2,3,4-tri-O-benzyl-b-d-xylo-
pyranosyl-(1!2)]-4,6-di-O-benzyl-a-d-mannopyranosyl-(1!3)-
[2,3,4-tri-O-benzyl-b-d-xylopyranosyl-(1!2)]-6-O-acetyl-4-O-
benzyl-a-d-mannopyranoside (29). DDQ (7.2 mg, 32 mmol) was
added to a vigorously stirred solution of 27 (45 mg, 15.7 mmol) in
CH2Cl2/tBuOH (1.6 mL, 10:1) at 20 8C. The progress of the reaction
was monitored by TLC (toluene/EtOAc, 9:1). After 60 min, the reac-
tion was quenched by adding satd. NaHCO3 solution (6 mL). The
resulting mixture was extracted once with CH2Cl2 (10 mL), the
layers were separated, and the organic layer was washed with 10%
aq. Na2S2O3 solution (6 mL), dried over MgSO4, and concentrated in
vacuo to a yellow oil. Purification by flash column chromatography
(SiO2, toluene/EtOAc, 94:6!70:30) gave 29 (42.8 mg, 68%) as a col-
ourless syrup: Rf=0.40 (toluene/EtOAc, 9:1) ; [a]D
20 ¢9.8 (c 1.0,
CHCl3) ;
1H NMR (500 MHz, CDCl3): d=7.57–6.86 (m, 85H), 5.33 (s,
1H), 5.16 (s, 1H), 5.14–5.06 (m, 2H), 5.05–4.98 (m, 3H), 4.88–4.78
(m, 6H), 4.76–4.54 (m, 13H), 4.53–4.40 (m, 6H), 4.38–4.18 (m, 9H),
4.17–3.89 (m, 15H), 3.85–3.75 (m, 2H), 3.75–3.34 (m, 17H), 3.33–
3.27 (m, 2H), 3.22 (ddd, J 13.1, 6.4, 3.8 Hz, 1H), 3.17–3.04 (m, 4H),
2.93 (dd, J 11.6, 9.3 Hz, 1H), 1.79 ppm (s, 3H); 13C NMR (125 MHz,
CDCl3): d=170.8, 168.1, 139.0, 139.0, 138.9, 138.8, 138.7, 138.6,
138.6, 138.6, 138.5, 138.5, 138.5, 138.3, 138.3, 138.2, 138.2, 138.0,
135.4, 129.2, 128.8, 128.8, 128.7, 128.7, 128.6, 128.6, 128.5, 128.4,
128.4, 128.4, 128.4, 128.3, 128.3, 128.3, 128.2, 128.1, 128.0, 128.0,
127.8, 127.8, 127.8, 127.7, 127.7, 127.6, 127.6, 127.5, 127.5, 127.5,
127.4, 125.9, 104.5, 104.0, 103.4, 102.7, 101.2, 99.9, 98.3, 84.3, 84.0,
83.4 (2C), 82.0, 81.7, 81.3, 80.5, 79.8, 79.0, 78.9, 78.6, 78.4, 78.2,
78.1, 77.9, 77.9, 77.4, 75.6, 75.6, 75.5, 75.4 (2C), 75.3, 75.2, 74.9,
74.8, 74.6, 74.5, 74.2, 74.0, 73.6 (2C), 73.4, 73.2, 73.2, 73.0, 72.0,
71.9, 70.5, 69.7, 68.9, 68.2, 67.2, 66.7, 64.2, 63.9, 63.7, 63.3, 50.4,
20.8 ppm; HRMS (ESI): [M+Na]+ m/z calcd for C162H171N3O35Na:
2741.1591, found: 2741.1567.
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